Swiss AI drug trial startup receives funding from Spotify-backer Creandum
A Swiss biotech startup focusing on AI-driven drug discovery received investment from Creandum, a venture firm known for backing Spotify. The company has built an AI foundation model trained on approximately two million human RNA readouts, designed to replace traditional animal testing and human trials with 12-week simulations.
Key points
- Swiss biotech startup funded by Creandum
- AI model trained on ~2 million human RNA sequences
- Aims to replace animal and human testing with simulations
Summary and key points written by AI from the headline and a short excerpt, so they can be incomplete or wrong. Economic Times Tech did the reporting; read the original for the full story.
Read the full story at Economic Times Tech
